Vazegepant HCl
CAS No. 1414976-20-7
Vazegepant HCl( —— )
Catalog No. M22411 CAS No. 1414976-20-7
Vazegepant is the first intranasal gepant for the acute treatment of migraine and has announced a positive phase II/III study.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 215 | In Stock |
|
10MG | 317 | In Stock |
|
25MG | 536 | In Stock |
|
50MG | 763 | In Stock |
|
100MG | 1053 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameVazegepant HCl
-
NoteResearch use only, not for human use.
-
Brief DescriptionVazegepant is the first intranasal gepant for the acute treatment of migraine and has announced a positive phase II/III study.
-
DescriptionVazegepant is the first intranasal gepant for the acute treatment of migraine and has announced a positive phase II/III study.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1414976-20-7
-
Formula Weight675.3
-
Molecular FormulaC36H47ClN8O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCl.CN1CCC(CC1)N1CCN(CC1)C(=O)[C@@H](Cc1cc(C)c2[nH]ncc2c1)NC(=O)N1CCC(CC1)c1cc2ccccc2[nH]c1=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Moreno-Ajona D , Abigail Pérez-Rodríguez, Goadsby P J . Gepants, calcitonin-gene-related peptide receptor antagonists: what could be their role in migraine treatment?[J]. Current Opinion in Neurology, 2020, 33(3):1.
molnova catalog
related products
-
Silydianin
Silydianin exerts inhibition of UGT in human liver. Silydianin exerts inhibition of OATP1B1 OATP1B3 expressed in HEK293 cells. Silydianin exerts inhibition of OATP2B1 expressed in MDCK2 cells.
-
Rehmannioside D
Rehmannioside D is a carotenoid glycoside that existed in the roots of Rehmannia glutinosa.
-
Isophorone
Isophorone (355-trimethyl-2-cyclohexen-1-one) a monoterpene and the structurally related 18-cineole and camphor have demonstrated a protective effect against cancer biological activity against a variety of microorganisms and anti-oxidant properties.